Sinovac, one of several Chinese companies developing Covid-19 vaccines, said it has raised $500m in funding to expand manufacturing of its CoronaVac candidate.
科興生物(Sinovac)表示,已籌到5億美元資金用于擴大其候選疫苗“克爾來福”(CoronaVac)的生產。中國有數家企業在研發新型冠狀病毒肺炎(COVID-19,即2019冠狀病毒病)疫苗,科興是其中之一。
您已閱讀14%(264字),剩余86%(1574字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。